Copyright
©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. Nov 5, 2021; 12(6): 103-112
Published online Nov 5, 2021. doi: 10.4292/wjgpt.v12.i6.103
Published online Nov 5, 2021. doi: 10.4292/wjgpt.v12.i6.103
Variable | Total | With castor oil | Without castor oil | P value |
Overall capsule completion | 144/186 (77) | 54/62 (87) | 90/124 (73) | 0.0128 |
Age: | ||||
≤ 60 | 67/78 (86) | 24/26 (92) | 43/52 (83) | 0.1250 |
> 60 | 77/108 (71) | 30/36 (83) | 47/72 (65) | 0.0253 |
Gender: | ||||
Male | 68/82 (83) | 25/28 (89) | 43/54 (80) | 0.1352 |
Female | 76/104 (73) | 29/34 (85) | 47/70 (67) | 0.0251 |
Indication: | ||||
Polyp surveillance | 75/96 (78) | 28/30 (93) | 47/66 (71) | 0.0075 |
Lower gastrointestinal symptoms | 36/42 (86) | 10/10 (100) | 26/32 (81) | 0.0450 |
Incomplete colonoscopy | 19/28 (68) | 7/11 (63) | 12/17 (7) | 0.3502 |
Anaemia | 12/18 (67) | 8/10 (80) | 4/8 (50) | 0.0899 |
IBD surveillance | 2/2 (100) | 1/1 (100) | 1/1 (100) | 1.0 |
- Citation: Semenov S, Ismail MS, O'Hara F, Sihag S, Ryan B, O'Connor A, O'Donnell S, McNamara D. Addition of castor oil as a booster in colon capsule regimens significantly improves completion rates and polyp detection. World J Gastrointest Pharmacol Ther 2021; 12(6): 103-112
- URL: https://www.wjgnet.com/2150-5349/full/v12/i6/103.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v12.i6.103